Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 223 of 1,261
  1. US 11517592

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  2. US 11517557

    Analogs of cyclobenzaprine and amitriptyline

    TONIX PHARMACEUTICALS HOLDING CORP · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  3. US 11517606

    Composition having anti-glycation effect and application thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  4. US 11518804

    Method of treating osteoarthritis with an antibody to NGF

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  5. US 11517584

    RNAi agents for Hepatitis B virus infection

    Arrowhead Pharmaceuticals, Inc. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  6. US 11518816

    Methods of delivering an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy

    Dyne Therapeutics, Inc. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  7. US 11518818

    Therapeutic anti-IgE antibodies and methods and compositions thereof

    The Regents of the University of California · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  8. US 11517524

    Film formulations containing dexmedetomidine and methods of producing them

    BioXcel Therapeutics, Inc. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  9. US 11517564

    Methods of treatment for cystic fibrosis

    Vertex Pharmaceuticals Incorporated · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  10. US 2022380379

    PHARMACEUTICAL COMPOUNDS

    HEPTARES THERAPEUTICS LTD [GB] · Granted Dec 1, 2022 · Expires Nov 26, 2042

    granted
  11. US 11512327

    Compositions and methods for delivery of AAV

    VOYAGER THERAPEUTICS, INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  12. US 11512128

    VEGF/DLL4 binding agents and uses thereof

    MEREO BIOPHARMA 5, INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  13. US 11510939

    RNAs for complement inhibition

    Apellis Pharmaceuticals, Inc. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  14. US 11510887

    Sobetirome in the treatment of myelination diseases

    United States Government as represented by the Department of Veterans Affairs · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  15. US 11510880

    Compositions and methods for organ specific delivery of nucleic acids

    The Board of Regents of the University of Texas System · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  16. US 11512313

    Functionally-interdependent shape switching nucleic acid nanoparticles

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  17. US 11512309

    Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  18. US 11512113

    Cleavable linker compositions and methods

    JANUX THERAPEUTICS, INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  19. US 11512080

    CRBN ligands and uses thereof

    Kymera Therapeutics, Inc. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  20. US 11512117

    Whole avian-origin reverse genetic system and recombinant H5N2 subtype avian influenza virus, vaccine and uses thereof

    SOUTH CHINA AGRICULTURAL UNIVERSITY · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  21. US 11512112

    Peptide for suppressing osteoclast differentiation and use thereof

    CAREGEN CO., LTD. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  22. US 11512066

    Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

    Takeda Pharmaceutical Company Limited · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  23. US 11512060

    1,2,4-oxadiazole derivatives as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  24. US 11511001

    Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.